Torrey Pines Investment
Venture capitalSan Diego · Seed–Series A · 7 people tracked
Investment thesis
Torrey Pines Investment focuses on the life-sciences sector, backing biopharma and diagnostics accelerators and investing in early development-stage assets from pharma and biotech partners across CNS, oncology, and virology areas. The firm aims to advance these assets toward success through pharma partnering and M&A. It supports portfolio companies with both product and corporate development, drawing on expertise in drug discovery — including non-clinical and clinical studies, manufacturing and quality, and regulatory affairs — to help them achieve growth, build value, and realize wealth.
Source: firm website, verified Aug 3, 2026.
Team · 7 people
from the firm's website & public directories
What they invest in
from 8 of 11 portfolio companiesBiotech ×8Healthtech ×5Deep Tech ×2AI & Machine Learning ×1
HQs:United States×3Finland×1
Investments · 11 tracked
founders shown can be your intro pathContext Therapeutics develops clinical-stage T cell engaging bispecific antibody therapies for the treatment of solid tumors.
BiotechHealthtechPhiladelphia, US
Martin Albert Lehr(Executive Officer, Director)Martin Lehr(Founder)inJennifer Minai-Azary(Executive Officer)Alex Levit(Executive Officer)Linda Beth West(Director)Richard Jay Berman(Director)
Co-investorsNextech Invest
Brenig Therapeutics is a biotechnology company developing small-molecule therapies for Parkinson's disease and other neurodegenerative disorders, using AI-driven drug discovery.
AI & Machine LearningBiotechHealthtech
Megan McGill(Chief Executive Officer)Iain Dukes(Chief Business Officer / Chairman of the Board)Nikolay Savchuk(Chief Operating Officer)Tien Dam(Chief Medical Officer)
Co-investorsNew Enterprise Associates (NEA)OrbiMedBGV
i2020 Accelerator (T123 LLC) is a drug discovery accelerator that de-risks early-stage science and advances drug discovery platforms toward lead and clinical candidate stage within roughly two years, working across therapeutic areas such as oncology, immunology, and infectious diseases.
BiotechDeep TechHealthtech
Co-investorsBioGeneration VenturesOrbiMed
Contract research organization specializing in CNS preclinical efficacy and neurotoxicity evaluations using its patented Enhanced Spine Profiling (ESP) technology.
Clinical-stage drug-device company developing pegloprastide (AVB-620) for real-time surgical margin detection in cancer surgery.
Chromis Thera is a pharmaceutical company developing drugs to treat viral diseases, including a Favipiravir-based treatment for COVID-19 and therapies targeting hepatitis B virus (HBV).
BiotechHealthtech
Oncology company developing targeted and immuno-oncology therapeutics; lead candidate DKN-01 targets the DKK1 protein.
BiotechCambridge, US
Christopher Mirabelli(Chief Executive Officer, President and Director)Augustine Lawlor(Chief Operating Officer)Douglas Onsi(Chief Financial Officer)Thomas Dietz(Director)Joseph Loscalzo(Director)Nissim Mashiach(Director)
Leap Therapeutics (Nasdaq: LPTX) develops targeted and immuno-oncology antibody therapeutics for cancer patients, with its lead candidate DKN-01 (sirexatamab), an anti-DKK1 monoclonal antibody, in clinical development for esophagogastric, gynecologic, and colorectal cancers.
BiotechHealthtech
Polku Therapeutics is a preclinical CNS drug discovery company developing small-molecule therapies that modulate the PREP–PP2A axis to target tau aggregation and neuroinflammation in neurodegenerative diseases.
BiotechDeep Tech
Timo(Scientific Co-founder)inErik(Scientific Co-founder)inSimon(Chief Executive Officer)inSebastian(Chief Operating Officer)in
Biotechnology company enhancing vaccine performance with its HD-MAP high-density microarray skin-delivery platform, targeting infectious disease and oncology.
Co-investorsR&D Tax IncentiveOneVentures
Exits · 1
IPOs and acquisitions across the tracked portfolioContext TherapeuticsNASDAQ: CNTX
Frequently asked questions
- How many investments has Torrey Pines Investment made?
- Torrey Pines Investment has 10 tracked investments.
- What stage does Torrey Pines Investment invest at?
- Torrey Pines Investment invests at the Seed, Series A stages.
- What sectors does Torrey Pines Investment focus on?
- Torrey Pines Investment focuses on Biotech, Digital Health, Healthtech, Medical Devices.
- Where is Torrey Pines Investment located?
- Torrey Pines Investment is headquartered in San Diego, US.
- Does Torrey Pines Investment lead rounds?
- Yes, Torrey Pines Investment leads investment rounds.
Images
Similar investors
.jpeg){kind=logo}
B Capital is a global investment firm backing early to late-stage technology innovators across technology, healthcare, and energy & resilience sectors.
Breyer Capital is a venture capital firm that backs high-impact entrepreneurs, making strategic investments guided by founder passion and its network of experienced investors.
DCVC (Data Collective) is a deep tech venture capital firm that backs entrepreneurs using computational approaches to solve large-scale real-world problems across many industries.
Eight Roads Ventures is a venture capital firm that backs and partners with technology and healthcare companies.
GV (Google Ventures) is a venture capital firm that has invested in artificial intelligence and machine learning since its early days, building a global portfolio of more than 100 AI companies across infrastructure, life sciences, and applications.